Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
ADAMTSL5 VHH recombinant monoclonal antibody
ADM VHH recombinant monoclonal antibody
ALB VHH recombinant monoclonal antibody
AMHR2 VHH recombinant monoclonal antibody
ANGPT2 VHH recombinant monoclonal antibody
ANGPTL3 VHH recombinant monoclonal antibody
AOC3 VHH recombinant monoclonal antibody
APCS VHH recombinant monoclonal antibody
APP VHH recombinant monoclonal antibody
AXL VHH recombinant monoclonal antibody
BAFFR VHH recombinant monoclonal antibody
BCMA VHH recombinant monoclonal antibody